News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
About the Author - Alex Keown

news@biospace.com

BioSpace News - By Alex Keown
285 Jobs at Risk as Biogen (BIIB) to Stop Producing Drugs at Its Cambridge Plant 6/28/2016
100+ Jobs Gone as Pfizer (PFE) to Shut Down Boulder Facility 6/28/2016
Sanofi (SNY) Gears Up for Second Round of Innovation Awards Grants 6/27/2016
AstraZeneca PLC (AZN), GlaxoSmithKline (GSK), Novartis AG (NVS) and Roche (RHHBY) React to Brexit and Its Possible Impact on Biotech 6/27/2016
British Trade Group Suspends Astellas (ALPMY) After Drugmaker Disguised the True Purpose of a Meeting Held for Doctors 6/27/2016
Takeda (TKPYY) Returns Certain Molecules, Products to Amgen (AMGN) 6/27/2016
GE Healthcare Opens Up $27 Million, 500-Job Facility in Massachusetts 6/24/2016
What Happens to Merck KGaA (MKGAF.PK) Jobs After the UK Voted Brexit 6/24/2016
Cambridge's Eleven Bio (EBIO) Pink Slips 70% of Workforce in Restructuring 6/24/2016
A Look into NW Bio (NWBO)'s Downfall: Bad Management or Short Sellers? 6/24/2016
Hedge Fund Exec Accused of Paying Former FDA Official for Inside Information Found Dead in Apparent Suicide 6/24/2016
Two Bay Area Startups Win Amgen (AMGN)'s Golden Ticket Award 6/24/2016
Massachusetts-Based Radius Health (RDUS) Opens Up Shop in Philadelphia with Plans to Hire 100+ Employees 6/23/2016
AstraZeneca PLC (AZN) Takes a $80 Million Hit as the CDC Says Flu Vaccine Flumist Does Not Work 6/23/2016
31-Year-Old Rachel Haurwitz Helms Hot CRISPR-Based Biotech Firm Caribou Biosciences 6/23/2016
What Pfizer (PFE) Could Look Like If it Breaks Up 6/23/2016
Sanofi (SNY) Partners Successfully with UMass Boston in Undergraduate STEM Program 6/23/2016
Immunomedics (IMMU) CFO Steps Down, Stock Has Fallen Steadily Since ASCO Fiasco 6/22/2016
Kite Pharma (KITE) Opens Up New T-Cell Therapy Manufacturing Plant in California 6/22/2016
Donors from Top 15 Drug Firms Drop Cash onto Presidential Candidate Hillary Clinton 6/22/2016
3 Big Data Risks Pharma Should Fear 6/22/2016
Silicon Valley Tech Titan Sean Parker to Back First CRISPR Test 6/22/2016
Opko Health (OPK) Rockets on FDA Approval of Rayaldee Four Months Ahead of PDUFA Date 6/22/2016
Biogen (BIIB)'s Cambridge Manufacturing Move Means More Work for the 1,300 Workers in North Carolina 6/21/2016
3 Big Pharmas Investors Should Take a Look At 6/20/2016
Endocyte (ECYT) Co-Founder Resigns Effective Immediately as CEO, New Leader Named 6/20/2016
Scancell (SCNLF) Suspends Dosing in Melanoma Trial Due to Quality Issues 6/17/2016
Theranos is Finally Going to Share Data on Its Blood Tests in August 6/17/2016
As Theranos Gets Dumped by Walgreens, Rival Quest Diagnostics (DGX) Moves into More Safeway Locations 6/16/2016
Former FDA Official Charged in Alleged Securities Scheme for Tipping Off Hedge Fund 6/16/2016
Google (GOOG)'s Verily Taps Communications Chief to Craft Company Message and Battle Media Criticism 6/16/2016
Shire (SHPG) Nabs Breakthrough Tags for Drug to Treat Rare Gastrointestinal Conditions 6/15/2016
Arena (ARNA) Board Terminates CMO Without Cause, Effective Immediately 6/15/2016
New York Startup Rgenix Bags $33 Million, Gears Up to Push Drug Once-Shelved by GlaxoSmithKline (GSK) into Trial 6/15/2016
Struggling Chiasma Chops 33% of Workforce After FDA Drug Rejection 6/15/2016
Beleaguered Cambridge Drugmaker Aegerion (AEGR) Merges with QLT (QLTI) to Survive 6/15/2016
Pfizer (PFE)-Backed Ziarco Exploring Sale, Deal Could Bring in $1 Billion+ 6/15/2016
Infinity Pharma (INFI) to Eliminate 46 Researchers After Lymphoma Drug Disappoints in Study 6/14/2016
Intarcia to Move HQ Next Month, Plans to Double Workforce By End of 2017 6/14/2016
Mesoblast (MSB.AX) Stock Sinks 42% After Teva (TEVA) Withdraws from Heart Failure Trials 6/14/2016
Novo Nordisk A/S (NVO) Investors Disappointed as Top Selling Drug Victoza Didn't Do as Well as Expected 6/14/2016
Walgreens Breaks Ties With Theranos, Will Shutter All 40 Wellness Centers 6/13/2016
Struggling Eleven Bio (EBIO) Forges Deal Worth $270 Million with Pharma Giant Roche (RHHBY) 6/13/2016
Jennifer Lawrence Signs On to Play Elizabeth Holmes in Movie About Embattled Theranos 6/13/2016
Pfizer (PFE) Quietly Raised Drug Prices By an Average of 8.8% Last Week 6/10/2016
Biogen (BIIB)'s $8 Billion Market Cap Drop Makes Thermo Fisher Scientific (TMO) the New King in Massachusetts, But GE Corporation (GE)’s Coming to Town 6/10/2016
BIO2016: French Firm Biose to Open U.S. HQ in Cambridge to Look for Partners 6/10/2016
Top Alphabet Exec Defends Google (GOOG)'s Verily Amid Criticism 6/9/2016
Boston Scientific (BSX) Aims for Major Cost Reductions in Global Restructuring 6/9/2016
Valeant (VRX) Scrambles to Restructure Deal with Walgreens 6/9/2016
BIO2016: Ireland Still Attracting Biotech, Pharma Companies to Set up Shop 6/9/2016
BIO2016: Months After Infamous "Sexist" Biotech Party, LifeSci Advisors Finds New Ways to Showcase Women 6/9/2016
Could Google (GOOG)'s Verily be the Next Theranos? 6/9/2016
Federal Judge Reverses Merck & Co. (MRK)’s $200 Million Patent Win Against Gilead (GILD) Over False Testimony 6/9/2016
BIO2016: Pharma Business Models Are Predicted To Shift To Patient Outcomes And Value 6/8/2016
Boston's Ginkgo BioWorks Bags $100 Million to Buy a Whole Lot of Synthetic DNA, Inks Deals with Twist Bioscience and Gen9 6/8/2016
Embattled Theranos Catches a Break, Says Only 1% of Tests Have Been Voided or Corrected 6/7/2016
Genentech (RHHBY), OSI Pharma (OSIP) to Fork Over $67 Million for Misleading Info About Cancer Drug Efficacy 6/7/2016
Lion Biotech Raises Approximately $100 Million and Names a New CEO 6/7/2016
3 Bargain Pharma Stocks to Watch 6/7/2016
Theranos CEO Elizabeth Holmes Will Get to Keep Her Honorary Doctorate from Pepperdine University 6/7/2016
3 Bargain Biotech Stocks to Buy Right Now 6/6/2016
ASCO2016: Genentech (RHHBY)'s TECENTRIQ Shrank Tumors in People with Previously Untreated Advanced Bladder Cancer 6/6/2016
ASCO2016: Immunomedics (IMMU) Breast Cancer Abstract Booted from Conference 6/6/2016
BIO2016: Biologics Consulting Launches Clinical Trials Planning and Oversight Group 6/6/2016
Shire (SHPG) to Hire Up to 200 New Employees for Baxalta (BXLT)'s Kendall Square Research Center 6/3/2016
What’s at the Heart of Alnylam (ALNY)'s Company Culture? 6/3/2016
Trio of Execs that Saved Martin Shkreli's Old Company KaloBios (KBIO) Could Get $700,000 Award 6/3/2016
Abbott (ABT) Tries to Bail Out of $5.8 Billion Deal as Alere (ALR) Faces Bribery Probes, But it Won't Be Easy 6/3/2016
FDA Approves Biogen (BIIB) and AbbVie (ABBV)'s Once-Monthly MS Drug Zinbryta 6/2/2016
Bay Area's StemCells (STEM) to Cease Operations After Ending Mid-Stage Study 6/2/2016
Peregrine (PPHM) Nixes Planned Trials for Bavituximab, But Hints at a Future Trial with AstraZeneca PLC (AZN)’s Durvalumab 6/2/2016
Ionis Pharma (IONS)'s Pain Propels Alnylam (ALNY) to Gain $1.5 Billion in Market Cap 6/1/2016
Former Valeant (VRX) CEO Nabs $9+ Million Severance Deal and Consulting Role 6/1/2016
Jazz Pharma (JAZZ) Pays $1.5 Billion for Celator Pharma (CPXX) to Gain a Promising Leukemia Drug 6/1/2016
Embattled Valeant (VRX) Reportedly Spurned a Takeover Offer from Takeda (TKPYY)-TPG 5/31/2016
Merck & Co. (MRK), Pfizer (PFE) and Others Join Forces to Fight California Drug Price Control Ballot Initiative 5/31/2016
Walgreens' Execs Ignored Doubts in Theranos' Technology in Fear of Deal Crumbling 5/27/2016
Genentech (RHHBY)’s Gazyva Meets Primary Endpoint Early in Late-Stage Study 5/27/2016
Thermo Fisher Scientific (TMO) Expands into Pharma Market, Antes Up $4.2 Billion for FEI Company 5/27/2016
Only One Week After Voiding Two Years of Tests, Theranos Now Faces Consumer Class Action Lawsuit 5/27/2016
Ionis Pharma (IONS) Plummets After GlaxoSmithKline (GSK) Opts Not to Initiate Phase III Study for Amyloid Cardiomyopathy Drug 5/27/2016
Retired Gilead (GILD) Exec Returns as His Replacement Exits 5/26/2016
Count Celgene (CELG) and Gilead (GILD) as New Suitors to Acquire the Popular Medivation (MDVN) 5/26/2016
Sophiris Bio (SPHS) Slashes Workforce in Half as Firm Explores Strategic Options 5/25/2016
Novartis AG (NVS) CEO Attempts to Rebuild as Seven Execs Jump Ship in the Space of Five Months 5/25/2016
Sanofi (SNY) Loses Three Top Execs, Reshuffles Executive Committee 5/24/2016
French Authorties Blame Both Biotrial and Bial Over Fatal Drug Trial 5/24/2016
M&A Targets Pfizer (PFE) and Others Could be Eyeballing 5/24/2016
Novartis AG (NVS)'s Pharma Head Exits as Drug Business is Split into Two 5/24/2016
10 Biotech Stocks Analysts are Upbeat About in May 5/23/2016
Fearless Theranos Eyes Expansion Despite Dealing with One Setback After Another 5/23/2016
NeuralStem to Cut an Unknown Number of Jobs in Reorganization 5/20/2016
Journalist Criticizes ZIOPHARM Oncology (ZIOP.OB) as Its Own ‘Biotech Bubble’ Held Aloft by Ties to R.J. Kirk's Intrexon (XON) 5/20/2016
About 500 Kendall Square Baxalta (BXLT) Staffers in Limbo as Shire (SHPG) Merger Talks Drag On 5/20/2016
3 Life Science Stocks Short-Sellers are Wrong About 5/20/2016
Embattled Theranos Tosses Out Two Years of Edison Blood Test Results 5/20/2016
AstraZeneca PLC (AZN) Hands Out Pink Slips to Unknown Number of Contract Sales Reps 5/19/2016
Enterome Opens Up U.S Office in Kendall Square 5/19/2016
AstraZeneca PLC (AZN) CEO's Big Experiment and His Take on Keeping Employees on Edge 5/19/2016
3 Biotech Stocks Investors Should Pick Up in May 5/18/2016
Navidea (NAVB) Shakeup Continues as CEO Rick Gonzalez is Now Out 5/18/2016
New York Could Be Next Booming Bio Hub as Cellectis (ALCLS), Pfizer (PFE) and Eli Lilly (LLY) Set Up Shop There 5/18/2016
Catalyst Pharma (CPRX) Axes 30% of Workforce to Conserve Cash 5/18/2016
Biogen (BIIB) Aligns with Two Super Stars and Bags a Deal with REGENXBIO in Gene Therapy Push 5/17/2016
Journalist Claims Intrexon (XON) CEO is Untrustworthy, Compares Firm to Theranos 5/17/2016
Theranos COO Abruptly Resigns, Company Adds New Board Members 5/17/2016
Aduro Biotech (ADRO)'s Stock Craters After Pancreatic Cancer Drug Trial Misses Primary Endpoint 5/17/2016
Bay Area's KineMed Files for Chapter 11, Owes $1 Million+ to NIH, Gates and Others 5/16/2016
Gutsy Sanofi (SNY) to Nominate 8 Directors for Medivation (MDVN) Board, Files Pre-Merger Papers 5/13/2016
Federal Agencies Want to Know More About Clovis Oncology (CLVS)'s Rociletinib Data from Last Fall 5/13/2016
Valeant (VRX)'s New CEO Criticized By Man Who Succeeded Him at Perrigo (PRGO) 5/13/2016
Chiasma Chief Says Firm May Challenge FDA Over Rare-Disease Drug Rejection 5/12/2016
Genentech (RHHBY) May Owe Refunds to Some Healthcare Providers Over 340B Price Violations 5/12/2016
Allergan (AGN) Reworking Its Executive Team, Outlines $10 Billion Stock Buyback as Q1 Revenue Falls Short 5/12/2016
Another Director, Accounting Firm Quit Navidea (NAVB), Lender Tried to Freeze Its Bank Accounts 5/11/2016
Pernix (PTX) CEO Steps Down, Effectively Immediately 5/11/2016
Bay Area's Alexza Pharma (ALXA) Sold in $35 Million Deal 5/11/2016
San Diego's Sorrento (SRNE) Hires Advisors to Mull Over Strategic Options 5/10/2016
AstraZeneca PLC (AZN) Employees from Shuttered Facility Could be Relocated to Delaware 5/10/2016
RXi Pharma (RXII) to Explore Strategic Options, Including Possible M&A 5/10/2016
BioDelivery (BDSI) Consolidating the Sales Force Size in Cost-Cutting Move 5/10/2016
Wildcat Capital Calls for Ouster of Sorrento (SRNE)'s CEO, Accuses Firm of Squandering Assets and Destroying Shareholder Value 5/9/2016
A Look at 4 People Molding Kendall Square's Future 5/9/2016
Investors Concerned as Endo Pharma (ENDP) Mimics the Path of Valeant (VRX) 5/9/2016
Endo Pharma (ENDP) to Cut 740 Employees and Shakes Up U.S. Senior Management in Restructuring 5/9/2016
Clovis Oncology (CLVS) to Eliminate 35% of Workforce and Ends All Trials of Lung Cancer Drug Rociletinib 5/9/2016
Look Who Google (GOOG)'s Verily Is Hiring 5/6/2016
Amgen (AMGN) Rumored to be Another Medivation (MDVN) Suitor 5/6/2016
Apple (AAPL) Taps Former Google X Cofounder for Health Push 5/6/2016
10 Massachusetts Biotechs Devoting the Most Cash to R&D 5/6/2016
Look Who’s Profiting from Gilead (GILD)'s Sky-High Hepatitis C Drug Prices 5/6/2016
Investors Disappointed as Merck & Co. (MRK) Sales of Januvia and Remicade Fall Short 5/5/2016
Booming Bay Area Biotech NGM Plans Move to Vacant Site Once Meant for Amgen (AMGN) 5/5/2016
Theranos Allegedly Sent Team of Five Lawyers to Wall Street Journal to Squash Story 5/4/2016
3 Bargain Biotechs to Buy 5/4/2016
IMS Health, Quintiles (Q) to Merge to Form $23 Billion Power House 5/4/2016
Backed by Celgene (CELG) and Novartis AG (NVS), IDEAYA Biosciences Raises $46 Million and Recruits an Arsenal Full of Industry Vets 5/4/2016
Delaware Employees Nervous Over AstraZeneca PLC (AZN)'s $1 Billion Cost-Cutting Plans 5/4/2016
Federal Judge Reopens Gilead (GILD) Case Amid Allegations Former Merck & Co. (MRK) Scientist Lied 5/3/2016
Cambridge's BIND Therapeutics (BIND) Files for Chapter 11 and Reviews Strategic Alternatives 5/3/2016
North Carolina's NephroGenex (NRX) Files for Chapter 11 and Seeks Sale 5/2/2016
Federal Health Regulators Release Lightly Redacted Theranos Report with More Details 5/2/2016
Sienna Biopharma Launches with $34 Million and a Roster Full of Former Kythera (KYTH) Execs 5/2/2016
FDA Sued for Not Disclosing More Info on the Experts Determining the Fate of Drugs and Devices 4/29/2016
Vertex (VRTX) CEO Took a 23% Pay Cut in 2015 as Firm Overhauls Compensation Policies 4/29/2016
Life Science Real Estate Developer Lands $310 Million Construction Loan for Cambridge R&D Project 4/29/2016
Biogen (BIIB) Poaches Star Pfizer (PFE) Scientist as New R&D Chief 4/29/2016
Alnylam (ALNY) Breaks Ground on New $200 Million Manufacturing Facility in Massachusetts, Adding 150 Jobs 4/29/2016
NantKwest CEO's $329.7 Million Pay Package Might Make Him the Highest-Paid U.S. Executive 4/29/2016
Pennsylvania’s Inovio Pharma (INO) Doubles Workforce, Continues Hiring Spree 4/28/2016
Valeant (VRX)'s New CEO Will Make Over $500 Million if Stock Hits $270 By 2020 4/28/2016
Backed by Celgene (CELG), Bay Area Startup FLX Bio Bags $50 Million to Push Lead Drug into Clinic 4/28/2016
Aurobindo Pharma (AUROBINDOP.BO) Adding 275 Jobs in Durham Despite Backlash Over LGBT Law 4/27/2016
Perrigo (PRGO) Names New CEO as Joseph Papa Joins Rival Valeant (VRX) 4/27/2016
ImmunoGen (IMGN) Taps Former Shire (SHPG) Exec as New CEO 4/27/2016
Seattle’s Adaptive Biotech Looks to Hire 50 Employees in 2016 to Buttress Fast Growth 4/26/2016
Allergan (AGN) Finally Breaks Ground on $200 Million Texas Expansion, Facility to Up Headcount by 100 4/26/2016
Critics Believe New Valeant (VRX) CEO Joe Papa Jumped from One Troubled Drugmaker to Another 4/26/2016
From 20 to 84 Employees in Just Four Years, Booming Blueprint Medicines (BPMC) Maps Out a Plan 4/26/2016
Deal Spree for AbbVie (ABBV) Continues with $500 Million Cancer Tie-Up with Bay Area's CytomX 4/25/2016
Eisai Company (ESALY.PK) Beefs Up Neurology Team with Ex-Pfizer (PFE), Sanofi (SNY) Execs 4/25/2016
Juno (JUNO), Five Prime (FPRX) are Quiet Winners at AACR 4/25/2016
Alere (ALR) Stock Falls as Abbott (ABT) CEO Declines to Comment and Confirm $6 Billion Deal 4/22/2016
Valeant (VRX) Close to Naming Perrigo (PRGO)'s Joseph Papa as New CEO 4/22/2016
AbbVie (ABBV) Gets First Dibs on arGEN-X's Immuno-Oncology Drug in Deal Worth $685 Million 4/21/2016
Novartis AG (NVS)'s U.S. Head Steps Down for Personal Reasons 4/21/2016
Argos (ARGS) Slashes 13% of Workforce to Complete a Phase III Study Under Budget, COO Resigns 4/21/2016
Theranos Director Defends Elizabeth Holmes, Says CEO is "Clearly Equipped" to Run Company 4/21/2016
Astex Pharma (ASTX) and Genentech (RHHBY) Forge a Clinical Trial Deal for Acute Myeloid Leukemia 4/20/2016
Bay Area’s GigaGen Develops Synthetic Immune System to Harness Antibodies 4/19/2016
Covered in $30 Billion Debt, Embattled Valeant (VRX) Mulls Over Which Assets to Sell 4/19/2016
Daiichi Sankyo Picks Location for New U.S. Headquarters 4/19/2016
Sanofi (SNY) to Drop $339 Million on Expansion of Belgium Biologics Drug Site 4/19/2016
Eli Lilly (LLY) Abandons Development of Transition Therapeutics (TTH.TO)' Diabetes Candidate TT401 4/19/2016
More Trouble for Elizabeth Holmes and Theranos as Federal Authorities Launch Criminal Probe 4/19/2016
Osiris (OSIR) Fires CMO Jon Hopper 4/18/2016
North Carolina’s Rho Looks at Untapped Talent Pools to Fill Jobs at Growing CRO 4/18/2016
Embarrassed by "Sexist" Biotech Party, LifeSci Promotes Gender Equality, Hires More Women 4/18/2016
Feds Propose Banning Theranos CEO Elizabeth Holmes from the Blood Testing Biz for at Least Two Years 4/18/2016
Bay Area's Carbylan to Suspend Clinical Development of Hydros-TA and Slash Jobs to Conserve Cash 4/15/2016
3 Biotechs Might Have M&A Targets On Their Backs 4/15/2016
Embattled Valeant (VRX) Working with Banks to Review Options Amid Interest from Buyout Firms 4/15/2016
Booming Seres Therapeutics Looks to Move Lead Product into Phase III, Expand in Cambridge 4/14/2016
Cydan Churns Out Second Rare Disease Biotech Imara with $31 Million 4/14/2016
India's Aurobindo Pharma (AUROBINDOP.BO) is Being Courted to Bring 200 Well-Paying Jobs to the City of Durham 4/14/2016
Clovis Oncology (CLVS) Takes Another Hit After An FDA Panel Votes Against Rociletinib 4/14/2016
Facebook, Napster Trailblazer Sean Parker Wagers $250 Million to Launch Cancer Immunotherapy Institute 4/14/2016
Fresh Off Its $1.2 Billion Deal, Gilead (GILD) Has Cash to Go Shopping Again 4/13/2016
Struggling Ariad (ARIA)'s Luck Might be Turning Around as Company Eyes Pfizer (PFE)'s ALK Space 4/13/2016
Valeant (VRX) Stock Falls on Default Fears, U.S. Rep. Criticizes Company Over Philidor 4/13/2016
Gilead (GILD) Seeks to Build Six-Story Lab in HQ Expansion, May House Up to 5,000 New Employees 4/12/2016
3 Depressed Biotechs that Investors with a Long-Term Perspective Should Buy Right Now 4/12/2016
Peter Thiel-Backed South San Francisco Firm Counsyl Cuts 27 Employees 4/12/2016
Juno (JUNO) Goes Global With Launch of New China-Based JW Biotechnology (Shanghai) Co. 4/11/2016
Theranos Takes a Shot at Redemption by Adding Experts to the Medical Board 4/11/2016
Valeant (VRX)’s Ackman Says Company Will Not Sell Bausch & Lomb 4/8/2016
Massachusetts’ Booming Cytel Hiring and Growing Fast in CRO Role 4/8/2016
Ackman Says New Valeant (VRX) CEO Will be Named Within Weeks 4/7/2016
Durham's Heat Biologics Slashes 22% of Workforce and Cuts Execs' Pay to Conserve Cash 4/7/2016



//-->